Akamai Technologies officer proposes sale of 2,013 shares

The listed entries trace the shares to restricted-stock lapses dated March 6, 2021, through June 1, 2021.

Rhea-AI Filing Summary

Akamai Technologies Inc. officer Kim Salem-Jackson filed notice of a proposed sale of 2,013 common shares, with an aggregate market value of $257,664.00. The notice lists September 25, 2026, as the approximate sale date and NASDAQ as the exchange. The securities table lists restricted-stock lapse entries dated March 6, April 26, May 13, May 14 and June 1, 2021, and identifies equity compensation as the payment nature.

Key Figures

Proposed shares to be sold: 2,013 common shares Aggregate market value: $257,664.00 Shares outstanding: 143,716,609 shares

3 metrics

Proposed shares to be sold 2,013 common shares Approximate sale date: September 25, 2026

Aggregate market value $257,664.00 Proposed sale

Shares outstanding 143,716,609 shares Listed in the securities information

Key Terms

Restricted Stock Lapse, equity compensation, Rule 144

3 terms

Restricted Stock Lapse technical

"Restricted Stock Lapse"

equity compensation financial

"Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AKAM shares did Kim Salem-Jackson propose to sell?

Officer Kim Salem-Jackson reported a proposed sale of 2,013 common shares with an aggregate market value of $257,664.00. The approximate sale date listed is September 25, 2026.

Which broker is listed for Kim Salem-Jackson's proposed AKAM sale?

Charles Schwab & Co., Inc. is listed as the broker for the proposed sale. The securities information also names NASDAQ as the exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/25/2026 - 04:41 PM Accepted by SEC EDGAR 09/25/2026 - 04:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001845739
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AKAMAI TECHNOLOGIES INC
SEC File Number	000-27275
Address of Issuer	145 BROADWAY CAMBRIDGE MASSACHUSETTS 02142
Phone	6174443000
Name of Person for Whose Account the Securities are To Be Sold	Salem-Jackson Kim
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	2013	257664.00	143716609	09/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/06/2021	Restricted Stock Lapse	Akamai Technologies, Inc.			507	03/06/2021	Equity Compensation
Common	04/26/2021	Restricted Stock Lapse	Akamai Technologies, Inc.			827	04/26/2021	Equity Compensation
Common	05/13/2021	Restricted Stock Lapse	Akamai Technologies, Inc.			220	05/13/2021	Equity Compensation
Common	05/14/2021	Restricted Stock Lapse	Akamai Technologies, Inc.			66	05/14/2021	Equity Compensation
Common	06/01/2021	Restricted Stock Lapse	Akamai Technologies, Inc.			393	06/01/2021	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Kim Salem-Jackson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)